[1] Li JX,Zhao YH,Zhao M,et al.High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease[J].Neurosurg Rev,2020,43(2):759~769. [2] Elkoushy MA,Metwally AH,Noureldin Y A.Implications of different nephrolithometry scoring systems on clinical practice of endourologists:an international web-based survey[J].Arab J Urol,2016,14(3):216~222. [3] Fujimura M,Bang OY,Kim JS.Moyamoya Disease [M].Intracranial Atherosclerosis:Pathophysiology,Diagnosis and Treatment,2016:204~220. [4] Sun T,Zeng Q,Huang LX,et al.Exploration of the risk factor for infarction after revascularization in moyamoya disease[J].Ann Med,2024,56(1):2362872. [5] Kim JH,Jeon H,Kim M,et al.Chemical and perfusion markers as predictors of moyamoya disease progression and complication types[J].Sci Rep,2024,14(1):56. [6] 烟雾病和烟雾综合征诊断与治疗中国专家共识编写组,国家卫生计生委脑卒中防治专家委员会缺血性卒中外科专业委员会.烟雾病和烟雾综合征诊断与治疗中国专家共识(2017)[J].中华神经外科杂志,2017,33(6):541~547. [7] Chen CY,Lin PT,Wang YH,et al.Etiology and risk factors of intracranial hemorrhage and ischemic stroke in young adults[J].J Chin Med Assoc,2021,84(10):930~936. [8] Zhang D,Huang L,Huang Z,et al.Epidemiology of moyamoya disease in China:a nationwide hospital-based study[J]. Lancet Reg Health-Western Pac,2022,18.7(11):1056~1066. [9] Kuroda S,Satoshi K.Moyamoya disease:current concepts and future perspectives[J].Lancet Neurol,2008,7(11):1056~1066. [10] 洪淑娥.烟雾病首发症状类型风险模型构建 [D].南昌:南昌大学,2018. [11] Al Kasab S,Nguyen TN,Derdeyn CP,et al.Emergent iarge vessel occlusion due to intracranial stenosis:identification,management,challenges,andfuture directions[J].Stroke,2024,55(2):355~365. [12] Zhang XC,Yang YP,Gan C,et al.Risk factors of transient neurological deficits and perioperative stroke after revascularization in patients with moyamoya disease[J].Brain Sci,2022,12(10):1285. [13] Castilla-Guerra L,Fernandez-Moreno MD.Chronic management of hypertension after stroke:the role of ambulatory blood pressure monitoring[J].J Stroke,2016,18(1):31~37. [14] 高静,王青桐,王志南,等.烟雾病患者搭桥手术后发生脑梗死的影响因素分析[J].山东医药,2021,61(11):73~76. [15] 林虎,姜美凤,王会中,等.血常规多项指标在 258 例烟雾病患者中的联合应用价值探讨[J].口岸卫生控制,2020,25(2):37~39. [16] Pang CH,Cho WS,Kang HS,et al.Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease[J].Sci Rep,2021,11(1):19367. [17] Chen ZY,Wu XQ,Zhou D,et al.Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis[J].Neurol Sci,2022,43(2):1087~1096. [18] 王阿俊,李楠,杨涛,等.烟雾病患者血脂代谢特点及其临床意义[J].立体定向和功能性神经外科杂志,2024(37):28~32. [19] Singh IM,Shishehbor MH,Ansell BJ.High-density lipoprotein as a therapeutic target a systematic review[J].JAMA,2007,298(7):786~798. [20] Kim J H,Jeon H,Kim M,et al.Chemical and perfusion markers as predictors of moyamoya disease progression and complication types[J].Sci Rep,2024,14(1):56. [21] Chen P,Wang Y,Li SF,et al.Development and external validation of nomogram for cerebral infarction in moyamoya diseases[J].Transl Stroke Res,2023,14(6):890~898. [22] Wang JX,Jiang HQ,Tang JW,et al.Postoperative cerebral infarction after revascularization in patients with moyamoya disease:Incidence and risk factors[J].Front Neurol,2022,13:1053193. |